(J61) Pneumoconiosis due to asbestos and other mineral fibres

More details coming soon

25 056 in individuals diagnosis pneumoconiosis due to asbestos and other mineral fibres confirmed

9 699 deaths with diagnosis pneumoconiosis due to asbestos and other mineral fibres

39% mortality rate associated with the disease pneumoconiosis due to asbestos and other mineral fibres

Etiology Pathogenesis Clinical Pattern Diagnostics Treatment Prevention

Diagnosis pneumoconiosis due to asbestos and other mineral fibres is diagnosed Men are 53.69% more likely than Women

19 254

Men receive the diagnosis pneumoconiosis due to asbestos and other mineral fibres

8 651 (44.9 %)

Died from this diagnosis.

100

5 802

Women receive the diagnosis pneumoconiosis due to asbestos and other mineral fibres

1 048 (18.1 %)

Died from this diagnosis.

Risk Group for the Disease pneumoconiosis due to asbestos and other mineral fibres - Men aged 75-79 and Women aged 65-69

In Men diagnosis is most often set at age 0-5, 50-94

Less common in men the disease occurs at Age 0-1, 5-49, 95+Less common in women the disease occurs at Age 0-59, 85-94

In Women diagnosis is most often set at age 60-84, 95+

Disease Features pneumoconiosis due to asbestos and other mineral fibres

Absence or low individual and public risk

Pneumoconiosis due to asbestos and other mineral fibres - what does this mean

Pneumoconiosis due to asbestos and other mineral fibres is an occupational lung disease caused by long-term inhalation of asbestos fibres in the workplace. it can cause scarring and thickening of the lungs, leading to difficulty breathing, coughing, and chest pain.

What happens during the disease - pneumoconiosis due to asbestos and other mineral fibres

Pneumoconiosis due to asbestos and other mineral fibres is caused by the inhalation of fibres which are then deposited in the lungs. these fibres cause an inflammatory response which can lead to scarring and fibrosis of the lungs, leading to the development of symptoms such as shortness of breath, chest pain, and coughing. long-term exposure to asbestos and other mineral fibres can lead to an increased risk of developing cancer.

Clinical Pattern

More details coming soon

How does a doctor diagnose

Chest X-ray
Spirometry
CT scan
Bronchoalveolar lavage
Lung biopsy
Sputum cytology
Pleural fluid analysis
Lung function tests

Additions:

Pulmonary function tests
Blood tests

Treatment and Medical Assistance

Main Goal: To reduce symptoms and improve the patient's quality of life.

Administering medications to reduce inflammation and pain
Providing oxygen therapy to improve breathing
Assisting with lifestyle changes to improve overall health
Recommending physical therapy to improve breathing and mobility
Recommending occupational therapy to manage daily activities
Recommending pulmonary rehabilitation to improve lung function
Referring to a specialist for further testing and treatment
Recommending a support group for emotional support
Recommending a diet plan to improve nutrition

20 Days of Hospitalization Required

Average Time for Outpatient Care Not Established

Pneumoconiosis due to asbestos and other mineral fibres - Prevention

The best way to prevent pneumoconiosis due to asbestos and other mineral fibres is to avoid exposure to asbestos and other mineral fibres. this can be done by wearing appropriate protective equipment, such as respirators, when working with these materials. additionally, employers should ensure that all workers are trained in proper safety procedures and are aware of the potential health risks associated with asbestos and other mineral fibres.

Diseases with similar symptoms